Stephen Elmore, MD
Rheumatology · Gainesville, GANPI 1467891564
Payments from drug & device makers
Across 1,062 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Amgen$3K
- UCB, Inc.$2K
- Novartis$2K
- Pfizer$1K
- Johnson & Johnson$918
- plus $5K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 296 | $4,542 |
| Amgen(2 entities) | 144 | $2,768 |
| UCB, Inc. | 136 | $2,029 |
| Novartis | 88 | $1,504 |
| Pfizer | 71 | $1,219 |
| Johnson & Johnson | 51 | $918 |
| AstraZeneca(2 entities) | 36 | $704 |
| E.r. Squibb & Sons, L.L.C. | 35 | $592 |
| Sanofi | 33 | $577 |
| GSK | 22 | $433 |
| Lilly USA, LLC | 24 | $397 |
| Aurinia Pharma U.S., Inc. | 26 | $397 |
| Genentech USA, Inc. | 15 | $297 |
| Organon | 12 | $258 |
| Radius Health, Inc. | 9 | $225 |
| Sobi, Inc | 11 | $198 |
| Bristol Myers Squibb | 15 | $198 |
| Octapharma USA, Inc. | 6 | $130 |
| Sandoz | 4 | $88 |
| ANI Pharmaceuticals, Inc. | 3 | $71 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Invivyd Inc | 2 | $41 |
| Merck | 3 | $41 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| Grifols USA, LLC | 2 | $37 |
| Medexus Pharma, Inc. | 3 | $36 |
| Boston Scientific | 1 | $31 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
How this compares
$17,998 in reported general payments places this provider in the 75th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Gainesville
- Brent FlickingerGainesville$1.6M
- Marta BognarGainesville$719K
- William ChafinGainesville$18K
- Huma SohailGainesville$14K
- Theresa Lawrence FordLawrenceville$2.9M
- Wambui MachuaAtlanta$1.8M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
- Arezou KhosroshahiAtlanta$1.5M
- Sung LimAtlanta$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.